leisure time -WSS

leisure time

author：focus 2025-09-28 00:48:05 - browse：997

Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill. -- health policy coverage from STAT — Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill in 2021. Susan Walsh/AP

WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT.

The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase. The committee has jurisdiction over Medicare and Medicaid payment policies for hospitals. Other committees that have tried tackling the issue have jurisdiction mostly over the Food and Drug Administration.

The panel is tentatively aiming to hold a hearing on the issue in November, the sources said. The panel has also started accepting input from outside stakeholders, one lobbyist said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Readout Newsletter: Merck, Vertex, and Viking updates

explore

WSS

Obesity now affects over 1 billion people worldwide, study finds

An inside look at PIPEs, biotech's buzzy new financing tool

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Scientists unlock the key to scar

leisure time

leisure time

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Why getting cancer drugs just got harder for rural patients

Virginia high school admissions case could be legal follow

Biotech companies concerned about China biosecurity crackdown

How one medical school became remarkably diverse

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

What does generative AI mean for health care? We asked experts

Abortion pill Supreme Court ruling could impact entire drug industry

Walensky prepares to leave CDC — and Congress — behind

FDA does about

focus

Why the world’s most expensive drug might be worth the price

AstraZeneca loses challenge to Medicare drug price negotiation

Primary care physicians play key roles in Alzheimer's management

Patient advocates debate FDA's accelerated approval process

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Supreme Court mifepristone arguments center on docs' right to sue

explore

focus

entertainment

hotspot